Insider Transactions in Q4 2023 at Aeglea Bio Therapeutics, Inc. (AGLE)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Fairmount Funds Management LLC |
BUY
Other acquisition or disposition
|
Indirect |
812,076
+50.0%
|
-
|
|
Dec 29
2023
|
Fairmount Funds Management LLC |
SELL
Other acquisition or disposition
|
Indirect |
3,435,480
-100.0%
|
-
|
|
Dec 22
2023
|
Scott L Burrows Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134,953
+50.0%
|
-
|
|
Nov 24
2023
|
Fairmount Funds Management LLC |
BUY
Conversion of derivative security
|
Indirect |
3,435,480
+50.0%
|
-
|
|
Nov 24
2023
|
Cameron Turtle Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
723,440
+49.22%
|
-
|